Sg Americas Securities, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Sg Americas Securities, LLC

  • $27.6 Billion
  • Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 3,390 shares of ALNY stock, worth $830,177. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,390
Previous 437 675.74%
Holding current value
$830,177
Previous $106,000 779.25%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024
BUY
$233.81 - $287.01 $690,440 - $847,540
2,953 Added 675.74%
3,390 $932,000
Q2 2024

Jul 12, 2024
SELL
$143.31 - $247.0 $5.49 Million - $9.46 Million
-38,318 Reduced 98.87%
437 $106,000
Q1 2024

May 06, 2024
BUY
$146.51 - $198.2 $5.58 Million - $7.55 Million
38,095 Added 5771.97%
38,755 $5.79 Million
Q4 2023

Jan 12, 2024
SELL
$151.41 - $196.57 $2.9 Million - $3.77 Million
-19,176 Reduced 96.67%
660 $126,000
Q3 2023

Oct 13, 2023
BUY
$170.77 - $211.65 $2.74 Million - $3.39 Million
16,025 Added 420.49%
19,836 $3.51 Million
Q2 2023

Jul 10, 2023
SELL
$185.01 - $212.05 $1.46 Million - $1.67 Million
-7,883 Reduced 67.41%
3,811 $724,000
Q1 2023

Apr 28, 2023
BUY
$182.66 - $235.53 $895,034 - $1.15 Million
4,900 Added 72.12%
11,694 $2.34 Million
Q4 2022

Feb 02, 2023
BUY
$185.53 - $241.31 $1.03 Million - $1.35 Million
5,575 Added 457.34%
6,794 $1.62 Million
Q3 2022

Oct 31, 2022
SELL
$138.54 - $232.0 $1.76 Million - $2.95 Million
-12,730 Reduced 91.26%
1,219 $244,000
Q2 2022

Jul 29, 2022
SELL
$120.42 - $169.29 $1.69 Million - $2.38 Million
-14,065 Reduced 50.21%
13,949 $2.03 Million
Q1 2022

Apr 29, 2022
BUY
$127.18 - $173.91 $2.44 Million - $3.33 Million
19,168 Added 216.69%
28,014 $4.57 Million
Q4 2021

Feb 07, 2022
SELL
$159.56 - $209.29 $325,661 - $427,160
-2,041 Reduced 18.75%
8,846 $1.5 Million
Q3 2021

Nov 01, 2021
SELL
$169.75 - $207.73 $1.39 Million - $1.7 Million
-8,185 Reduced 42.92%
10,887 $2.06 Million
Q2 2021

Aug 12, 2021
BUY
$128.63 - $176.89 $2.11 Million - $2.9 Million
16,386 Added 610.05%
19,072 $3.23 Million
Q1 2021

May 13, 2021
BUY
$126.83 - $175.69 $50,858 - $70,451
401 Added 17.55%
2,686 $379,000
Q4 2020

Feb 04, 2021
SELL
$122.97 - $147.0 $113,009 - $135,093
-919 Reduced 28.68%
2,285 $297,000
Q3 2020

Nov 09, 2020
SELL
$121.19 - $165.49 $1.28 Million - $1.75 Million
-10,553 Reduced 76.71%
3,204 $467,000
Q2 2020

Jul 20, 2020
BUY
$104.21 - $156.44 $1.04 Million - $1.57 Million
10,015 Added 267.64%
13,757 $2.04 Million
Q1 2020

Apr 30, 2020
BUY
$93.12 - $133.99 $46,466 - $66,861
499 Added 15.39%
3,742 $407,000
Q4 2019

Jan 28, 2020
BUY
$74.51 - $124.23 $109,529 - $182,618
1,470 Added 82.91%
3,243 $373,000
Q3 2019

Nov 04, 2019
BUY
$70.9 - $87.82 $125,705 - $155,704
1,773 New
1,773 $143,000
Q2 2019

Jul 29, 2019
SELL
$65.86 - $92.79 $8.81 Million - $12.4 Million
-133,828 Closed
0 $0
Q1 2019

Apr 29, 2019
BUY
$72.76 - $93.45 $8.31 Million - $10.7 Million
114,143 Added 579.85%
133,828 $12.5 Million
Q4 2018

Feb 01, 2019
BUY
$62.67 - $88.33 $642,680 - $905,824
10,255 Added 108.75%
19,685 $1.44 Million
Q3 2018

Nov 06, 2018
BUY
$87.52 - $122.67 $407,143 - $570,660
4,652 Added 97.36%
9,430 $825,000
Q2 2018

Aug 07, 2018
SELL
$88.31 - $107.8 $1.6 Million - $1.95 Million
-18,108 Reduced 79.12%
4,778 $471,000
Q1 2018

May 03, 2018
BUY
$115.92 - $148.54 $2.65 Million - $3.4 Million
22,886 New
22,886 $2.73 Million
Q4 2017

Jan 24, 2018
SELL
$114.49 - $139.98 $176,085 - $215,289
-1,538 Closed
0 $0
Q3 2017

Nov 07, 2017
BUY
$72.53 - $118.27 $111,551 - $181,899
1,538
1,538 $181,000

Others Institutions Holding ALNY

# of Institutions
642
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email